Proteomic maps of breast cancer subtypes

Nature Communications

Volumn 7, Issue , 2016, Pages

  Tyanova, Stefka ^a   Albrechtsen, Reidar ^b   Kronqvist, Pauliina ^c   Cox, Juergen ^a   Mann, Matthias ^a   Geiger, Tamar ^a,d  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF TURKU   (Finland)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ADENOSINE TRIPHOSPHATE SYNTHASE 5; ADENOSINE TRIPHOSPHATE SYNTHASE 6; AMINO ACID TRANSFER RNA LIGASE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; COLLAGEN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 6; CYCLINE; DNA POLYMERASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FIBRONECTIN; GLUTAMINE; INTERFERON REGULATORY FACTOR 3; LAMININ; MESSENGER RNA; NDUF PROTEIN; PROGESTERONE RECEPTOR; PROSTAGLANDIN SYNTHASE; PROTEIN; PROTEIN C JUN; PROTEOME; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SUCCINATE DEHYDROGENASE; THROMBOSPONDIN 1; THROMBOSPONDIN 2; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; UQCR PROTEIN; TRANSCRIPTOME;

CANCER; CLASSIFICATION; DISEASE TREATMENT; DNA; GENETIC ANALYSIS; PROTEIN; PROTEOMICS; RNA; SUPPORT VECTOR MACHINE;

ACCURACY; AMINO ACID SYNTHESIS; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER STAGING; CELL COMMUNICATION; CELL DEATH; CELL GROWTH; CELL HETEROGENEITY; CELL PROLIFERATION; CHROMOSOME 17; CLINICAL FEATURE; CONTROLLED STUDY; COPY NUMBER VARIATION; DOWN REGULATION; ENERGY METABOLISM; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; GLUCONEOGENESIS; GLYCOLYSIS; GLYCOSYLATION; GROWTH; HUMAN; HUMAN CELL; HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 POSITIVE BREAST CANCER; HUMAN TISSUE; OXIDATIVE PHOSPHORYLATION; PROGESTERONE RECEPTOR POSITIVE BREAST CANCER; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY CHAIN; RNA TRANSLATION; SIGNAL TRANSDUCTION; STANDARD; SUPPORT VECTOR MACHINE; TISSUE STRUCTURE; TRIPLE NEGATIVE BREAST CANCER; TRYPTOPHAN METABOLISM; TUMOR MICROENVIRONMENT; UNINDEXED SEQUENCE; UPREGULATION; BREAST TUMOR; CLASSIFICATION; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; PROCEDURES;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTEOMICS; TRANSCRIPTOME;

EID: 84953251229     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10259     Document Type: Article

References (45)

1. Reis-Filho, J. S., Pusztai, L. Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet 378, 1812-1823 (2011).
2. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000).
3. Sorlie, T. et al. Repeated observation of breast tumour subtypes in independent gene expression data sets. Proc. Natl Acad. Sci. USA 100, 8418-8423 (2003).
4. TCGA. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
5. Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346-352 (2012).
6. Geiger, T., Cox, J., Mann, M. Proteomic changes resulting from gene copy number variations in cancer cells. PLoS Genet. 6, e1001090 (2010).
7. Zhang, B. et al. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382-387 (2014).
8. Nagaraj, N. et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548 (2011).
9. Schwanhausser, B. et al. Global quantification of mammalian gene expression control. Nature 473, 337-342 (2011).
10. Mann, M., Kulak, N. A., Nagaraj, N., Cox, J. The coming age of complete, accurate, and ubiquitous proteomes. Mol. Cell 49, 583-590 (2013).
11. Ong, S. E. et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386 (2002).
12. Geiger, T., Cox, J., Ostasiewicz, P., Wisniewski, J. R., Mann, M. Super-SILAC mix for quantitative proteomics of human tumour tissue. Nat. Methods 7, 383-385 (2010).
13. Ostasiewicz, P., Zielinska, D. F., Mann, M., Wisniewski, J. R. Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry. J. Proteome Res. 9, 3688-3700 (2010).
14. Wisniewski, J. R., Zougman, A., Nagaraj, N., Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359-362 (2009).
15. Wisniewski, J. R., Zougman, A., Mann, M. Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. J. Proteome Res. 8, 5674-5678 (2009).
16. Michalski, A. et al. Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol. Cell. Proteomics 10, M111-011015 (2011).
17. Cox, J., Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372 (2008).
18. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
19. Doane, A. S. et al. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene 25, 3994-4008 (2006).
20. Yang, F. et al. Laser microdissection and microarray analysis of breast tumours reveal ER-alpha related genes and pathways. Oncogene 25, 1413-1419 (2006).
21. Smid, M. et al. Subtypes of breast cancer show preferential site of relapse. Cancer Res. 68, 3108-3114 (2008).
22. Bowie, M. L. et al. Interferon regulatory factor-1 regulates reconstituted extracellular matrix (rECM)-mediated apoptosis in human mammary epithelial cells. Oncogene 26, 2017-2026 (2007).
23. Farmer, P. et al. Identification of molecular apocrine breast tumours by microarray analysis. Oncogene 24, 4660-4671 (2005).
24. Grandvaux, N. et al. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76, 5532-5539 (2002).
25. Seki, E. et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13, 1324-1332 (2007).
26. Desmedt, C. et al. Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin. Cancer Res. 14, 5158-5165 (2008).
27. Parker, J. S. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160-1167 (2009).
28. Saal, L. H. et al. Recurrent gross mutations of the PTEN tumour suppressor gene in breast cancers with deficient DSB repair. Nat. Genet. 40, 102-107 (2008).
29. Hurtado, A., Holmes, K. A., Ross-Innes, C. S., Schmidt, D., Carroll, J. S. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet. 43, 27-33 (2011).
30. Boser, B. E., Guyon, I. M., Vapnik, V. N. in Proceedings of the 5th Annual Workshop on Computational Learning Theory COLT'92 (ACM Press, Pittsburgh, PA, USA, 1992).
31. Vapnik, V. N. The nature of statistical learning theory (NY Springer, 1995).
32. Possemato, R. et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476, 346-350 (2011).
33. Dong, C. et al. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 23, 316-331 (2013).
34. Ben-Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumours. Nat. Genet. 40, 499-507 (2008).
35. van 't Veer, L. J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536 (2002).
36. Jerby, L. et al. Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer. Cancer Res. 72, 5712-5720 (2012).
37. Morani, F. et al. PTEN deficiency and mutant p53 confer glucose-addiction to thyroid cancer cells: impact of glucose depletion on cell proliferation, cell survival, autophagy and cell migration. Genes Cancer 5, 226-239 (2014).
38. Cox, J. et al. Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment. J. Proteome Res. 10, 1794-1805 (2011).
39. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria (2012). Available at www.R-project.org/.
40. Cox, J., Mann, M. 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data. BMC Bioinform. 13 (Suppl 16): S12 (2012).
41. Benjamini, Y., Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 57, 289-300 (1995).
42. Tennekes, M., Jonge, E. Top-down data analysis with treemaps. in Proceedings of the International Conference on Information Visualization Theory and Applications IVAPP (Algarve, Portugal, 2011).
43. Chang, C. C., Lin, C. J. LIBSVM: a library for support vector machines. ACM Trans. Intell. Syst. Technol. 2, 1-27 (2011).
44. Robin, X. et al. pROC: an open-source package for R and S\+ to analyze and compare ROC curves. BMC Bioinform. 12, 77 (2011).
45. Tusher, V. G., Tibshirani, R., Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA 98, 5116-5121 (2001).